Kentaro Horikawa

1.4k citations
55 papers · 997 indexed · h-index 18
Topics
Complement system in diseases (17 papers)Acute Myeloid Leukemia Research (9 papers)Immune Cell Function and Interaction (8 papers)

In The Last Decade

Kentaro Horikawa

54 papers receiving 978 citations

Peers

Kentaro Horikawa
Comparison fields: 5 of 83
  • Hematology 484
  • Immunology 456
  • Molecular Biology 369
  • Nephrology 178
  • Genetics 175
Replace Shintaro Shiobara with:
Shintaro Shiobara Japan
Wendell Rosse United States
Linus Chang Australia
J. H. Crookston Canada
G Steiger Switzerland
Philippe Rousselot France
Florinda Gilsanz Spain
Berta Fusté Spain
Françoise Picard France
E Ueda Japan
Kentaro Horikawa relative to Shintaro Shiobara Japan Shintaro Shiobara's profile →
Citations per field
00.5×3.4×
Shintaro Shiobara · 1×
Citations per year

Countries citing papers authored by Kentaro Horikawa

Since Specialization
Citations

This map shows the geographic impact of Kentaro Horikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kentaro Horikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kentaro Horikawa more than expected).

Fields of papers citing papers by Kentaro Horikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kentaro Horikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kentaro Horikawa. The network helps show where Kentaro Horikawa may publish in the future.

Co-authorship network of co-authors of Kentaro Horikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kentaro Horikawa. A scholar is included among the top collaborators of Kentaro Horikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kentaro Horikawa. Kentaro Horikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 30
3 18
4 8
5 16
6 1
7 37
8 7
9 1
10 111
11 16
12 96
13 21
14 7
15 30
16 14
17 12
18 25
19 33
20 4

About Kentaro Horikawa

Kentaro Horikawa is a scholar working on Physiology, Hematology and Immunology, having authored 55 papers that have together received 997 indexed citations. Recurring topics across this work include Complement system in diseases (17 papers), Acute Myeloid Leukemia Research (9 papers) and Immune Cell Function and Interaction (8 papers). The work is most often cited by research in Hematology (484 citations), Nephrology (178 citations) and Immunology (456 citations). Kentaro Horikawa has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Hideki Nakakuma, Shoichi Nagakura, Tatsuya Kawaguchi, Tadashi Kagimoto, Norihiro Iwamoto, Kiyoshi Takatsuki, Hiroaki Mitsuya, Norio Asou, Michihiro Hidaka and Masaya Okada. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026